Zhen Cheng
Academic Appointments
- Assistant Professor (Research), Radiology - Diagnostic Radiology
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 723-7866Alternate Contact Patricia Riley Administrative Associate Email Tel Work (650) 723-8312
Professional Overview
Administrative Appointments
- Member, Canary Center at Stanford for Cancer Early Detection (2009 - present)
- Member, Stanford Cancer Center (2007 - present)
- Member, Bio-X Program (2007 - present)
- Member, Molecular Imaging Program at Stanford (MIPS) (2007 - present)
Honors and Awards
- Best Basic Science Paper Published in 2009, Journal of Nuclear Medicine (2010)
- New Investigator Award, Department of Defense (2009)
- Young Investigator Award, Melanoma Research Alliance (2009)
- IDEA Award, California Breast Cancer Research Program (2008)
Professional Education
| B.S.: | Sichuan University, Chemistry (1994) |
| M.S.: | China Institute of Atomic Energy, Radiopharmaceutical Chemistry (1997) |
| Ph.D.: | University of Missouri-Columbia, Chemistry (2001) |
Internet Links
Scientific Focus
Current Research Interests
The overall objective of my laboratory is to develop novel molecular imaging probes and techniques for non-invasive detection of cancer and its metastasis at the earliest stage, so that cancer can be cured or transformed into a chronic, manageable disease. The techniques developed in my research will allow a close examination of the molecular, metabolic and physiological characteristics of cancers and their responses to therapy. In order to achieve this goal, my lab is aimed to identify novel cancer biomarkers with significant clinical relevance, develop new chemistry for probes preparation, and validate new strategies for probes high-throughput screening.
Publications
- 18F-Fluorobenzoate-Labeled Cystine Knot Peptides for PET Imaging of Integrin αvβ6. J Nucl Med. 2013
- A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging. Amino Acids. 2013; (2): 673-81
- Affibody modified and radiolabeled gold-Iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials. 2013; (11): 2796-806
- Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma. J Med Chem. 2013; (3): 895-901
- Evaluation of (89)Zr-rituximab Tracer by Cerenkov Luminescence Imaging and Correlation with PET in a Humanized Transgenic Mouse Model to Image NHL. Mol Imaging Biol. 2013
- First (18)F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts. Nucl Med Biol. 2013
Help